Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Stratasys
SSYS
$781M
| $12.1M | 0.02% |
730,900
-79,632
| -10% | -$1.56M |
|
1102
Unisys
UIS
$206M
| $12.1M | 0.02% |
807,090
-132,600
| -14% | -$1.69M |
|
|
CYBE
1103
DELISTED
Cyberoptics Corp
CYBE
| $12M | 0.02% |
461,100
+45,900
| +11% | +$1.2M |
|
1104
Descartes Systems
DSGX
$6.5B
| $12M | 0.02% |
561,900
+98,500
| +21% | +$2.09M |
|
|
MIK
1105
DELISTED
Michaels Stores, Inc
MIK
| $12M | 0.02% |
586,600
+468,200
| +395% | +$10.9M |
|
1106
Energizer
ENR
$1.55B
| $12M | 0.02% |
268,600
+244,600
| +1,019% | +$11.2M |
|
|
WPX
1107
DELISTED
WPX Energy, Inc.
WPX
| $12M | 0.02% |
+822,000
| New | +$10.9M |
|
1108
FTI Consulting
FCN
$4.15B
| $12M | 0.02% |
265,600
+20,700
| +8% | +$900K |
|
|
BCOV
1109
DELISTED
Brightcove, Inc.
BCOV
| $12M | 0.02% |
1,485,483
+74,783
| +5% | +$730K |
|
1110
CRA International
CRAI
$1.06B
| $11.9M | 0.02% |
325,731
+74,131
| +29% | +$2.34M |
|
|
SREV
1111
DELISTED
ServiceSource International, Inc.
SREV
| $11.9M | 0.02% |
2,092,046
+307,972
| +17% | +$1.64M |
|
|
LDR
1112
DELISTED
Landauer Inc
LDR
| $11.8M | 0.02% |
246,000
+59,700
| +32% | +$2.81M |
|
|
IPHI
1113
DELISTED
INPHI CORPORATION
IPHI
| $11.8M | 0.02% |
264,600
-402,500
| -60% | -$17.3M |
|
1114
Ameris Bancorp
ABCB
$6.03B
| $11.8M | 0.02% |
270,483
-28,600
| -10% | -$1.16M |
|
|
SASR
1115
DELISTED
Sandy Spring Bancorp Inc
SASR
| $11.7M | 0.02% |
292,900
+34,500
| +13% | +$1.19M |
|
1116
Cisco
CSCO
$440B
| $11.7M | 0.02% |
387,200
-1,410,105
| -78% | -$43M |
|
|
MASI
1117
DELISTED
Masimo
MASI
| $11.7M | 0.02% |
173,400
+94,900
| +121% | +$5.83M |
|
|
RRD
1118
DELISTED
RR Donnelley & Sons Co.
RRD
| $11.7M | 0.02% |
+715,993
| New | +$12.9M |
|
1119
Advance Auto Parts
AAP
$3.38B
| $11.7M | 0.02% |
+68,950
| New | +$10.8M |
|
|
FFIC
1120
DELISTED
Flushing Financial
FFIC
| $11.7M | 0.02% |
396,600
+38,000
| +11% | +$965K |
|
1121
Take-Two Interactive
TTWO
$46.1B
| $11.7M | 0.02% |
236,450
-1,763,800
| -88% | -$83.3M |
|
|
OLP
1122
One Liberty Properties
OLP
$533M
| $11.7M | 0.02% |
463,889
+45,700
| +11% | +$1.1M |
|
|
TEN
1123
Tsakos Energy Navigation Ltd
TEN
$1.25B
| $11.6M | 0.02% |
495,920
+9,080
| +2% | +$214K |
|
|
ECOL
1124
DELISTED
US Ecology, Inc.
ECOL
| $11.6M | 0.02% |
236,500
-50,900
| -18% | -$2.3M |
|
|
ENH
1125
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $11.6M | 0.02% |
125,800
+21,400
| +20% | +$1.96M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.